Tech Company Financing Transactions
Glen Clova Scientific Funding Round
Glen Clova Scientific closed a $5 million Seed financing round on 4/25/2024. Investors included Norcliffe Capital, Scottish Enterprise and The Tricapital Syndicate.
Transaction Overview
Company Name
Announced On
4/25/2024
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Investors
Proceeds Purpose
The funding enables the Company to advance preclinical development of three initial drugs: GCS001 for treatment of senile pruritus, GCS002 for atopic dermatitis and GCS003 for eczema and asthma.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
272 Bath Street
Glasgow, Lanarkshire, Scotland, G2 4JR
UK
Glasgow, Lanarkshire, Scotland, G2 4JR
UK
Phone
Undisclosed
Website
Email Address
Overview
To move beyond current Biologic drugs and create Active Biologic drugs allowing patients to form natural antibodies against harmful targets. To make high quality treatment for chronic disease available for a demographic not able to access conventional Biologic drugs and contribute toward affordable healthcare globally.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
John Foerster
Co-Founder
Steven Powell
Browse more venture capital transactions:
Prev: 4/25/2024: Wheelhouse venture capital transaction
Next: 4/25/2024: Amae Health venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs